Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 793INDUSTRY 290NIH 156NETWORK 84OTHER_GOV 11UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 36Stomach Neoplasms 19Esophageal Neoplasms 17Carcinoma, Non-Small-Cell Lung 13Colorectal Neoplasms 12Rectal Neoplasms 11Triple Negative Breast Neoplasms 9Lung Neoplasms 8Brain Neoplasms 8Small Cell Lung Carcinoma 7Squamous Cell Carcinoma of Head and Neck 6Neoplasms 6Neoplasm Metastasis 6Esophageal Squamous Cell Carcinoma 6Nasopharyngeal Carcinoma 5Melanoma 4Lymphoma, Extranodal NK-T-Cell 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Recurrence 3Meningeal Carcinomatosis 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Colonic Neoplasms 3Vomiting 2Urinary Bladder Neoplasms 2Skin Diseases 2Sarcoma 2

Interventions

endostar protein 1camrelizumab 1apatinib 1Gemcitabine 1Endostatins 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Sarcoma × Clear all
NCT04447274 2020-06-25

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

ChineseAMS

Phase 2 Unknown
20 enrolled
Sarcoma

Sarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡